Body iron stores and early neurologic deterioration in acute cerebral infarction.
BACKGROUND
Iron-dependent free radicals formation has been related to greater damage in cerebral ischemia. The authors analyzed whether increased body iron stores were associated with early neurologic worsening and excitatory amino acid release in patients with acute ischemic stroke.


METHODS
Ferritin, total iron, and glutamate concentrations in plasma and CSF were measured on admission in 100 consecutive patients with a cerebral infarction of <24 hours' duration. The authors diagnosed progressing stroke when the Canadian Stroke Scale score decreased one or more points between admission and 48 hours. Cranial CT was performed on admission and repeated on days 4 to 7 of hospitalization.


RESULTS
Ferritin concentrations in plasma (median 391, range 119 to 500 versus 148, 21 to 399 ng/mL) and in CSF (17.4, 6.8 to 82, versus 4.8, 0.6 to 14 ng/mL) were significantly higher in the 45 patients with subsequent progressing stroke than in those with nonprogressing stroke (p < 0.001). There was a positive correlation between ferritin and glutamate concentrations in plasma (r = 0.81, p < 0.001) and CSF (r = 0.64, p < 0.001). Plasma ferritin concentrations >275 ng/mL in plasma (OR, 33.5; 95% CI, 4.7 to 235) and >11 ng/mL in CSF (OR, 11.4; 95% CI, 3. 1 to 41) were independently and significantly related to early neurologic worsening. The effect was reduced by >60% after controlling for glutamate concentrations, but remained significant.


CONCLUSIONS
High plasma and CSF ferritin concentrations within the first 24 hours from the onset of ischemic stroke are associated with early neurologic deterioration. Increased body iron stores may contribute to stroke progression by enhancing the cytotoxic mechanisms in cerebral ischemia.
Dávalos
A
A
Sections of Neurology, Hospital Universitari Doctor Josep Trueta, Girona, Spain.
Castillo
J
J
Marrugat
J
J
Fernandez-Real
J M
JM
Armengou
A
A
Cacabelos
P
P
Rama
R
R
D000208:Acute Disease; D000368:Aged; D001921:Brain / Q000000981:diagnostic imaging; D002545:Brain Ischemia / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism*; D002544:Cerebral Infarction / Q000097:blood / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000209:etiology; D018450:Disease Progression; D004311:Double-Blind Method; D005260:Female; D005293:Ferritins / Q000097:blood / Q000134:cerebrospinal fluid; D018698:Glutamic Acid / Q000097:blood / Q000134:cerebrospinal fluid; D006801:Humans; D007501:Iron / Q000097:blood* / Q000134:cerebrospinal fluid*; D016015:Logistic Models; D008297:Male; D016017:Odds Ratio; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
D018698:Glutamic Acid; D005293:Ferritins; D007501:Iron